1,493
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Participating in a vaccine trial for COVID-19 in Senegal: trust and information

ORCID Icon, ORCID Icon, , , ORCID Icon &
Pages 3907-3912 | Received 18 Apr 2021, Accepted 27 Jun 2021, Published online: 19 Jul 2021

References

  • Chabrol F. Biomedicine, public health, and citizenship in the advent of antiretrovirals in Botswana: the advent of antiretrovirals in Botswana. Dev World Bioeth. 2014;14:75–82. doi:10.1111/dewb.12051.
  • Lachenal G. Le médicament qui devait sauver l’Afrique: un scandale pharmaceutique aux colonies. Paris (France): La Découverte; 2014.
  • Moulin AM, Chabrol F, Ouvrier A. Chapitre 24. Histoire d’un vaccin pas comme les autres : les premiers pas du vaccin contre l’hépatite B au Sénégal. In: Delaunay V, Desclaux A, Sokhna C, editors. Niakhar, mémoires et perspectives. Montpellier (France): IRD Éditions;2018. p. 489–510. doi:10.4000/books.irdeditions.31872.
  • Koster W, Ndione AG, Adama M, Guindo I, Sow I, Diallo S, Sakandé J, Ondoa P. An oral history of medical laboratory development in francophone West African countries. Af J Lab Med. 2021;10. doi:10.4102/ajlm.v10i1.1157.
  • Ouvrier A. La recherche médicale en Afrique est un moyen pour l’Occident de tester des médicaments dangereux. Des idées reçues en santé mondiale. Montréal (Canada): Presses de l’Université de Montréal. p. 215–18; 2015. doi:10.4000/books.pum.3607
  • Petryna A. Globalizing human subjects research. In: Petryna A, Lakoff A, Kleinman A, editors. Global pharmaceuticals. Durham: Duke University Press; 2006. p. 33–60. doi:10.1215/9780822387916-002.
  • Moulin A-M. Patriarchal science: the network of the overseas pasteur institutes. Science and empires historical studies about scientific development and European expansion; Dordrecht: Springer Science + Business Media; 1992. p. 307–22.
  • Holding M, Ihekweazu C, Stuart JM, Oliver I. Learning from the epidemiological response to the 2014/15 ebola virus disease outbreak. JEGH. 2019; [cited 16] Feb 2020. doi:10.2991/jegh.k.190808.002.
  • Desclaux A, Badji D, Ndione AG, Sow K. Accepted monitoring or endured quarantine? Ebola contacts’ perceptions in Senegal. Soc Sci Med. 2017;178:38–45. doi:10.1016/j.socscimed.2017.02.009.
  • N’koué Sambiéni E, Danko N, Ridde V. La Fièvre Hémorragique à Virus Lassa au Bénin en 2014 en contexte d’Ebola : une épidémie révélatrice de la faiblesse du système sanitaire. Anthropologie Et Santé. 2015 [cited 2017 Jan 11]. doi:10.4000/anthropologiesante.1772.
  • Salyer SJ, Maeda J, Sembuche S, Kebede Y, Tshangela A, Moussif M, Ihekweazu C, Mayet N, Abate E, Ouma A.O. et al. The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study. The Lancet. 2021;S0140673621006322. doi:10.1016/S0140-6736(21)00632-2.
  • Tilley. COVID-19 across Africa: colonial hangovers, racial hierarchies, and medical histories. J West Afr His. 2020;6:155. doi:10.14321/jwestafrihist.6.2.0155.
  • Ridde V, Ouedraogo S, Yaya S. Closing the diversity and inclusion gaps in francophone public health: a wake-up call. BMJ Glob Health. 2021;6:e005231. doi:10.1136/bmjgh-2021-005231.
  • Büyüm AM, Kenney C, Koris A, Mkumba L, Raveendran Y. Decolonising global health: if not now, when? BMJ Glob Health. 2020;5:e003394. doi:10.1136/bmjgh-2020-003394.
  • Hellmann F, Williams-Jones B, Garrafa V. COVID-19 and moral imperialism in multinational clinical research. Arch Med Res. 2020;51:572–73. doi:10.1016/j.arcmed.2020.04.017.
  • Desclaux A Covid-19: en Afrique de l’Ouest, le vaccin n’est pas le nouveau «magic bullet»; 2021 [accessed 2021 June 11]. https://vih.org/20210202/la-mondialisation-des-informations-et-la-fabrique-des-opinions-sur-les-traitements-du-covid-en-afrique/.
  • Ouvrier M-A, Geissler W, Moulin A-M. Faire de la recherche médicale en Afrique: ethnographie d’un village-laboratoire sénégalais. Paris (France): IRD; 2015. p. 228.
  • Kana MA, LaPorte R, Jaye A. Africa’s contribution to the science of the COVID-19/SARS-CoV-2 pandemic. BMJ Glob Health. 2021;6:e004059. doi:10.1136/bmjgh-2020-004059.
  • Nkeck JR, Ndoadoumgue AL, Temgoua MN. COVID 19 pandemic, status of clinical trials in Africa on May 2020: need to reinforce. Pan Afr Med J. 2020:35. doi:10.11604/pamj.supp.2020.35.2.24349.
  • Wentzell E, Racila A-M. The social experience of participation in a COVID-19 vaccine trial: subjects’ motivations, others’ concerns, and insights for vaccine promotion. Vaccine. 2021:S0264410X21003170. doi:10.1016/j.vaccine.2021.03.036.
  • Brotherton H, Usuf E, Nadjm B, Forrest K, Bojang K, Samateh AL, Bittaye M, Roberts CA, d’Alessandro U, Roca A, et al. Dexamethasone for COVID-19: data needed from randomised clinical trials in Africa. The Lancet Global Health. 2020;8:e1125–e1126. doi:10.1016/S2214-109X(20)30318-1.
  • Desclaux A. L’acceptabilité du vaccin anti-COVID en AOC. Dakar (Sénégal); CRCF/IRD; 2020.
  • Ridde V, Kane B, Gaye I, Ba F, Diallo A, Bonnet E, Traoré Z, Faye A Acceptability of government measures against Covid-19 pandemic in Senegal: a mixed methods study. In Review. Dec 2020. doi:10.21203/rs.3.rs-131071/v1.
  • Riandey B, Blöss-Widmer I. Introduction aux sondages à l’usage du plus grand nombre. 2009 [accessed 2021 June 11]. https://hal.archives-ouvertes.fr/hal-01272371.
  • Huijts NMA, Molin EJE, Steg L. Psychological factors influencing sustainable energy technology acceptance: a review-based comprehensive framework. Renew Sustain Energy Rev. 2012;16:525–31. doi:10.1016/j.rser.2011.08.018.
  • Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res. 2017;17:88. doi:10.1186/s12913-017-2031-8.
  • Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York (USA): Wiley-Interscience Publication; 2000.
  • Zhang Z. Model building strategy for logistic regression: purposeful selection. Annal Trans Med. 2016;4:4–10. doi:10.21037/atm.2016.02.15.
  • Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020;38:7002–06. doi:10.1016/j.vaccine.2020.09.041.
  • Sethi S, Kumar A, Mandal A, Shaikh M, Hall CA, Kirk JMW, Moss P, Brookes MJ, Basu S. The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond. Trials. 2021;22:296. doi:10.1186/s13063-021-05250-4.
  • Kaljee L, Pach A, Stanton B. Applied anthropology, vaccine trials and feasibility studies: intersections of local knowledge, biomedicine, and policy. Pract Anthropol. 2011;33:39–43. doi:10.17730/praa.33.4.j14752n270j1w761.
  • Shah SK, Miller FG, Darton TC, Duenas D, Emerson C, Lynch HF, Jamrozik E, Jecker NS, Kamuya D, Kapulu M, et al. Ethics of controlled human infection to address COVID-19. Science. 2020;368(6493):832–34. doi:10.1126/science.abc1076.
  • Feldman-Savelsberg P, Ndonko FT, Sterilizing S-EB. Vaccines or the politics of the womb: retrospective study of a rumor in cameroon. Med Anthropol Q. 2000;14:159–79. doi:10.1525/maq.2000.14.2.159.
  • O’Neill S, Dierickx S, Okebe J, Dabira E, Gryseels C, d’Alessandro U, Peeters Grietens K. The Importance of blood is infinite: conceptions of blood as life force, rumours and fear of trial participation in a fulani village in rural gambia. Gregson A, editor. PLoS ONE. 2016;11:e0160464. doi:10.1371/journal.pone.0160464.
  • Felemban RM, Tashkandi EM, Mohorjy DK. The willingness of the Saudi Arabian population to participate in the COVID-19 vaccine trial: a case-control study. J Taibah Univ Med Sci. 2021. doi:10.1016/j.jtumed.2021.03.001.
  • de Vries H. An integrated approach for understanding health behavior; The I-Change model as an example. PBSIJ. 2017:2. doi:10.19080/PBSIJ.2017.02.555585.
  • Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger JA. Vaccine hesitancy: an overview. Hum Vaccin Immunother. 2013;9:1763–73. doi:10.4161/hv.24657.
  • Moulin A-M, Thomas G L’hésitation vaccinale, ou les impatiences de la santé mondiale. La vie des idées; 2021 [accessed 2021 June 11]. https://laviedesidees.fr/L-hesitation-vaccinale-ou-les-impatiences-de-la-sante-mondiale.html.
  • Godin G, Kok G. The theory of planned behavior: a review of its applications to health-related behaviors. Am J Health Promot. 1996;11:87–98. doi:10.4278/0890-1171-11.2.87.
  • Bangura JB, Xiao S, Qiu D, Ouyang F, Chen L. Barriers to childhood immunization in sub-Saharan Africa: a systematic review. BMC Public Health. 2020;20:1108. doi:10.1186/s12889-020-09169-4.
  • Laouan FZ. West Africa rapid gender analysis for COVID-19. CARE, Bamako, Mali; 2020. p. 21.
  • Wassenaar DR, Barsdorf NW. The ethical involvement of women in HIV vaccine trials in Africa: discussion paper developed for the African AIDS vaccine programme. Women Health. 2007;45:37–50. doi:10.1300/J013v45n01_03.
  • Marchetti E, Mazarin-Diop V, Chaumont J, Martellet L, Makadi M-F, Viviani S, Kulkarni PS, Preziosi M-P. Conducting vaccine clinical trials in sub-Saharan Africa: operational challenges and lessons learned from the meningitis vaccine project. Vaccine. 2012;30:6859–63. doi:10.1016/j.vaccine.2012.09.008.
  • Latkin C, Dayton L, Yi G, Konstantopoulos A, Park J, Maulsby C, Kong X. COVID-19 vaccine intentions in the United States, a social-ecological framework. Vaccine. 2021;S0264410X21002383. doi:10.1016/j.vaccine.2021.02.058.
  • Jamison AM, Quinn SC, Freimuth VS. “You don’t trust a government vaccine”: narratives of institutional trust and influenza vaccination among African American and white adults. Soc Sci Med. 2019;221:87–94. doi:10.1016/j.socscimed.2018.12.020.
  • Warren RC, Forrow L, Hodge DA, Truog RD. Trustworthiness before trust — covid-19 vaccine trials and the black community. N Engl J Med. 2020;383:e121. doi:10.1056/NEJMp2030033.
  • Bollyky TJ, Kickbusch I. Preparing democracies for pandemics. BMJ. 2020:m4088. doi:10.1136/bmj.m4088.
  • CIVICUS Monitor. National civic space ratings. Johannesburg (South Africa); 2021 [accessed 2021 June 11]. https://monitor.civicus.org.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.